One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Cancer drug discovery at warp speed: can AI deliver?
doi : 10.1016/S1470-2045(25)00431-0
Volume 26, Issue 8, August 2025, Page 981
Total neoadjuvant therapy with immunotherapy in locally advanced rectal cancer
Decoding the genomic landscape of early-onset colorectal cancer: the next chapter in precision oncology
Improved prognostication of surgically treated patients with HPV-positive oropharyngeal carcinoma
Unpublished overall survival confounders in immunomodulatory agent registrational trials
Unpublished overall survival confounders in immunomodulatory agent registrational trials – Authors' reply
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX – Authors' reply
CRISPR-engineered T-cell therapies: some clarifications needed – Authors' reply
Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus
Government action on cancer deaths that cost the UK economy £10·3 billion per year
US cancer research might never recover from proposed Trump funding cuts
New legislation set to improve drug access for American patients with cancer
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial
Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysis
Therapeutic geographies of cancer in conflict: cancer care in Iraq
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas
Epithelioid sarcoma presenting as a progressively enlarging wound
